Measles vaccine and the course of subacute sclerosing panencephalitis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 80702)

Published in Lancet on October 07, 1978

Authors

N A Halsey, W Schubert, J T Jabbour, S R Preblud

Articles by these authors

Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem (2001) 7.03

Ethics and international research. BMJ (1997) 4.70

Measles antibody: reevaluation of protective titers. J Infect Dis (1990) 3.77

Rational strategy for rubella vaccination. Lancet (1983) 3.61

Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis. Pediatrics (1977) 2.45

Patterns of transmission in measles outbreaks in the United States, 1985-1986. N Engl J Med (1989) 2.41

Limiting infant exposure to thimerosal in vaccines and other sources of mercury. JAMA (1999) 2.26

A persistent outbreak of measles despite appropriate prevention and control measures. Am J Epidemiol (1987) 2.13

Congenital rubella syndrome in the United States, 1970-1985. On the verge of elimination. Am J Epidemiol (1989) 2.12

Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression. JAMA (1994) 2.11

Molecular genetic evidence for early evolutionary origin of budding peptidoglycan-less eubacteria. Nature (1984) 2.05

Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain (2000) 2.04

From the Center for Disease control: current status of measles in the United States, 1973--1977. J Infect Dis (1978) 1.91

A mixture model with detection limits for regression analyses of antibody response to vaccine. Biometrics (1995) 1.87

Childhood survival in Haiti: protective effect of measles vaccination. Pediatrics (1990) 1.83

Appropriate age for measles vaccination in the United States. Dev Biol Stand (1986) 1.80

Isolation of measles virus from brain cell cultures of two patients with subacute sclerosing panencephalitis. Proc Soc Exp Biol Med (1969) 1.77

Age-specific risks of varicella complications. Pediatrics (1981) 1.76

Current status of mumps and mumps vaccine in the United States. Pediatrics (1978) 1.71

Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J (1990) 1.70

Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group. J Infect Dis (1998) 1.69

Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses. N Engl J Med (1985) 1.68

Epidemiology of pertussis, Atlanta, 1977. J Pediatr (1981) 1.62

Latissimus dorsi myocutaneous flap reconstruction of neck and axillary burn contractures. Plast Reconstr Surg (2000) 1.61

Subacute sclerosing panencephalitis. A multidisciplinary study of eight cases. JAMA (1969) 1.59

Measles outbreak among unvaccinated preschool-aged children: opportunities missed by health care providers to administer measles vaccine. Pediatrics (1989) 1.57

Bacillus Calmette-Guérin complications in children born to HIV-1-infected women with a review of the literature. Pediatrics (1995) 1.56

Control of hepatitis B: to be or not to be? Pediatrics (1992) 1.54

Rubella vaccination in the United States: a ten-year review. Epidemiol Rev (1980) 1.53

Prospective comparison of panoramic tomography (zonography) and helical computed tomography in the diagnosis and operative management of mandibular fractures. Plast Reconstr Surg (2001) 1.53

Maternal IgG1 and IgA antibody to V3 loop consensus sequence and maternal-infant HIV-1 transmission. Lancet (1994) 1.50

Fetal risk associated with rubella vaccine: an update. Rev Infect Dis (1985) 1.50

The M cell as a portal of entry to the lung for the bacterial pathogen Mycobacterium tuberculosis. Immunity (1999) 1.50

Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection. Am J Respir Crit Care Med (1996) 1.48

Localization of the putative precursor of Alzheimer's disease-specific amyloid at nuclear envelopes of adult human muscle. EMBO J (1988) 1.43

Geographic variation in the humoral response to Pneumocystis carinii. J Infect Dis (1993) 1.42

Varicella: complications and costs. Pediatrics (1986) 1.41

Comparison of live attenuated cold-adapted and avian-human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children. J Infect Dis (1990) 1.40

Varicella: clinical manifestations, epidemiology and health impact in children. Pediatr Infect Dis (1985) 1.39

Possible influence of carbamazepine on plasma imipramine concentrations in children with attention deficit hyperactivity disorder. J Clin Psychopharmacol (1990) 1.38

Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12-13, 2000. Pediatrics (2001) 1.35

Optimized expression of green fluorescent protein in Toxoplasma gondii using thermostable green fluorescent protein mutants. Mol Biochem Parasitol (2001) 1.35

The utility of verbal autopsies for identifying HIV-1-related deaths in Haitian children. AIDS (1993) 1.34

The A/Mallard/6750/78 avian-human, but not the A/Ann Arbor/6/60 cold-adapted, influenza A/Kawasaki/86 (H1N1) reassortant virus vaccine retains partial virulence for infants and children. J Infect Dis (1991) 1.28

Varicella vaccine trials in healthy children. A summary of comparative and follow-up studies. Am J Dis Child (1984) 1.26

Assessment of susceptibility to measles and rubella. JAMA (1982) 1.26

Universal immunization to interrupt rubella. Rev Infect Dis (1985) 1.25

Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. J Infect Dis (1983) 1.24

Prevalence of HIV-1 DNA and p24 antigen in breast milk and correlation with maternal factors. J Acquir Immune Defic Syndr (1994) 1.24

A benefit-cost analysis of a childhood varicella vaccination programme. Postgrad Med J (1985) 1.24

Saturday night fever: a common-source outbreak of rubella among adults in Hawaii. Am J Epidemiol (1981) 1.20

The opportunity and obligation to eliminate rubella from the United States. JAMA (1984) 1.20

Functional imaging of mitochondria in saponin-permeabilized mice muscle fibers. J Cell Biol (1998) 1.20

Differential mortality by measles vaccine titer and sex. J Infect Dis (1993) 1.20

Measles among the Amish: a comparative study of measles severity in primary and secondary cases in households. J Infect Dis (1991) 1.20

Epidemiology of subacute sclerosing panencephalitis (SSPE). A report of the SSPE registry. JAMA (1972) 1.19

Hemihypertrophy. Pediatrics (1965) 1.19

A mixed gamma model for regression analyses of quantitative assay data. Vaccine (1996) 1.19

Use of ethnographic research for instrument development in a case-control study of immunization use in Haiti. Int J Epidemiol (1989) 1.15

A school-based measles outbreak: the effect of a selective revaccination policy and risk factors for vaccine failure. Am J Epidemiol (1990) 1.14

Deaths from varicella in infants. Pediatr Infect Dis (1985) 1.14

Intralitter transmission of haemophilus influenzae type b in infant rats and rifampin eradication of nasopharyngeal colonization. J Infect Dis (1980) 1.14

Serum antibody response to pneumococcal vaccine in children with nephrotic syndrome. Pediatrics (1982) 1.13

Effect of food coupon incentives on timely completion of DTP immunization series in children from a low-income area in Karachi, Pakistan: a longitudinal intervention study. Vaccine (2010) 1.11

Silicone breast implants and immune disease. Ann Plast Surg (1992) 1.11

Preventing rubella: assessing missed opportunities for immunization. Am J Public Health (1987) 1.11

Methods of assessing the impact of congenital rubella infection. Rev Infect Dis (1985) 1.10

Some current issues relating to rubella vaccine. JAMA (1985) 1.10

Measles and measles vaccine efficacy in a remote island population. Bull World Health Organ (1982) 1.10

Simultaneous hypoglycemia and acute congestive heart failure. Circulation (1969) 1.09

A benefit-cost analysis of mumps vaccine. Am J Dis Child (1982) 1.08

Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J Clin Oncol (1996) 1.07

Cerebral arteritis and bacterial meningitis. Arch Neurol (1984) 1.07

Mumps in the workplace. Further evidence of the changing epidemiology of a childhood vaccine-preventable disease. JAMA (1988) 1.07

Immunizations in college health: the remaining tasks. J Am Coll Health (1987) 1.06

Adult onset of subacute sclerosing panencephalitis. Arch Neurol (1973) 1.06

Measles case fatality ratio in India a review of community based studies. Indian Pediatr (2009) 1.06

Clinical case definitions for Argentine hemorrhagic fever. Clin Infect Dis (1999) 1.05

Recurrent nosocomial polymicrobial sepsis secondary to child abuse. Lancet (1983) 1.04

Fatal measles pneumonia without rash in a child with AIDS. J Infect Dis (1988) 1.04

Widespread HIV counseling and testing linked to a community-based tuberculosis control program in a high-risk population. Bull Pan Am Health Organ (1996) 1.04

Prevention of rubella transmission in medical facilities. JAMA (1982) 1.03

Chickenpox in the United States, 1972--1977. J Infect Dis (1979) 1.03

Subacute sclerosing panencephalitis in the Middle East: report of 99 cases. Ann Neurol (1977) 1.02

A comparison of mutations induced by accelerated iron particles versus those induced by low earth orbit space radiation in the FEM-3 gene of Caenorhabditis elegans. Mutat Res (2001) 1.00

Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group. J Infect Dis (1997) 0.99

Herpes simplex virus type 2 infection, syphilis, and hepatitis B virus infection in Haitian women with human immunodeficiency virus type 1 and human T lymphotropic virus type I infections. The Johns Hopkins University (JHU)/Centre pour le Developpement et la Santé (CDS) HIV Study Group. J Infect Dis (1992) 0.99

CD8+CD103+ T cells analogous to intestinal intraepithelial lymphocytes infiltrate the pancreas in chronic pancreatitis. Am J Gastroenterol (1998) 0.98

Risk factors in subacute sclerosing panencephalitis: a case-control study. Am J Epidemiol (1980) 0.98

The distally based radial forearm fascia-fat flap for treatment of recurrent de Quervain's tendonitis. J Hand Surg Am (2001) 0.98

Cultural feasibility studies in preparation for clinical trials to reduce maternal-infant HIV transmission in Haiti. AIDS Educ Prev (1998) 0.98

A measles outbreak at a college with a prematriculation immunization requirement. Am J Public Health (1991) 0.98

Human immunodeficiency virus neutralizing antibodies in sera from North Americans and Africans. J Acquir Immune Defic Syndr (1990) 0.97

Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients. Lancet (1982) 0.97

HIV risk behavior and medical status of underprivileged youths in Belo Horizonte, Brazil. J Adolesc Health (1994) 0.96

Perspectives on the relative resurgence of mumps in the United States. Am J Dis Child (1988) 0.96